The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Franchini Indrani Lall since 2018.
This trader's CIK number is 1708764.
At the time of last reporting, Franchini Indrani Lall was the EVP, CLO & Secretary of Alnylam Pharmaceuticals, Inc.. (stock ticker symbol ALNY).
Also see all insider trading activities at Alnylam Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ALXN | 0 | $0 | 6,853 | $786,758 | 0 | $0 |
| 2019 | ALXN | 0 | $0 | 4,500 | $597,510 | 0 | $0 |
| 2018 | ALXN | 0 | $0 | 5,530 | $651,188 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ALNY | 0 | $0 | 1,920 | $323,781 | 6,053 | $0 |
| 2023 | ALNY | 0 | $0 | 5,175 | $1,113,454 | 5,175 | $0 |
1. Alexion Pharmaceuticals, Inc. (ALXN)
2. Alnylam Pharmaceuticals, Inc. (ALNY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-06-08 | ALXN | Sale | 6,853 | 114.81 | 786,758 |
| 2019-07-01 | ALXN | Sale | 4,500 | 132.78 | 597,510 |
| 2018-11-28 | ALXN | Sale | 2,605 | 118.13 | 307,728 |
| 2018-06-08 | ALXN | Sale | 1,466 | 118.53 | 173,764 |
| 2018-02-08 | ALXN | Sale | 1,459 | 116.31 | 169,696 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-27 | ALNY | Option Ex | 878 | .00 | 0 |
| 2024-02-28 | ALNY | Sale | 329 | 156.35 | 51,439 |
| 2024-02-02 | ALNY | Sale | 1,591 | 171.18 | 272,342 |
| 2024-02-01 | ALNY | Option Ex | 5,175 | .00 | 0 |
| 2023-04-06 | ALNY | Sale | 3,500 | 210.00 | 735,000 |
| 2023-02-01 | ALNY | Option Ex | 5,175 | .00 | 0 |
| 2023-02-02 | ALNY | Sale | 1,675 | 225.94 | 378,454 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Franchini Indrani Lall (EVP, CLO & Secretary of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.